2025-521603-46-00招募中1 期
A study testing a new treatment called TK-6302 for the first time in people with advanced cancers that have a genetic marker called HLA-A02:01 and a tumour protein called PRAME.
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- T-Knife GmbH
- 入组人数
- 24
- 试验地点
- 3
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
Michael Loveridge
Scientific
T-Knife GmbH
研究点 (3)
Loading locations...
相似试验
招募中
1 期
A phase I of TG6050 in the treatment of patients with metastatic lung cancer2024-513093-22-00Transgene36
已完成
1 期
Study to Evaluate the Safety and Efficacy of Treatment with NLM-001 before Standard Chemotherapy plus Zalifrelimab in Patients with Advanced Pancreatic Cancer2024-518852-22-00Nelum Corp.28
招募中
1 期
KO-2806 Monotherapy and Combination Therapies in Advanced Solid TumorsRenal Cell CarcinomaColorectal Cancer2024-513285-19-00Kura Oncology Inc.68
招募中
1 期
A Phase 1 study of GSK5764227 in participants with advanced solid tumors2024-513663-10-01Glaxosmithkline Research & Development Limited, Glaxosmithkline Research & Development Limited112
招募中
2 期
A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic AsthmaNCT07323654Kymera Therapeutics, Inc.264